Page last updated: 2024-08-26

mafosfamide and Leukemia, Biphenotypic, Acute

mafosfamide has been researched along with Leukemia, Biphenotypic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chelstrom, LM; Gunther, R; Jansen, B; Jaszcz, WB; Kersey, JH; Nguyen, DP; Tuel-Ahlgren, L; Uckun, FM1

Other Studies

1 other study(ies) available for mafosfamide and Leukemia, Biphenotypic, Acute

ArticleYear
Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.
    Leukemia, 1993, Volume: 7, Issue:2

    Topics: Acute Disease; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents, Phytogenic; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cyclophosphamide; Female; Humans; Immunotoxins; Leukemia, Biphenotypic, Acute; Leukemic Infiltration; Male; Mice; Mice, SCID; Molecular Sequence Data; N-Glycosyl Hydrolases; Oligonucleotide Probes; Plant Proteins; Polymerase Chain Reaction; Ribosome Inactivating Proteins, Type 1; Specific Pathogen-Free Organisms; Translocation, Genetic

1993